Overview
Maddison Masaeli is founder and chief executive officer of Deepcell, a company combining AI and high-resolution imaging to decode cell identity and function, empowering scientists to see biology as it truly is per the about page. Deepcell emerged from early days within Stanford University labs alongside individuals dedicated to biological discoveries.
Deepcell bridges life science, data, and technology to extract actionable insights through the lens of cell morphology — analyzing cells by visual phenotype rather than solely by surface markers or genetic labels.
Role and company
As Founder and CEO, Masaeli leads Deepcell alongside co-founder Mahyar Salek, President and CTO, and COO Kevin Farrell per the about page leadership roster. Deepcell blends AI-powered technology, microfluidics, and high-resolution optics across biological domains to fuel discoveries in cell science.
Deepcell’s Scientific Advisory Board includes Stanford-affiliated researchers Euan Ashley, Catherine Blish, and Christina Curtis — reflecting Masaeli’s academic founding roots at Stanford.
Background and career context
Deepcell’s about page describes origins within Stanford University labs without listing Masaeli’s full academic credentials on the cited page reviewed. Her public identity is tied to morphological cell analysis innovation — a technique positioning cells by shape and structure detectable through imaging AI.
Masaeli’s CEO role spans scientific credibility with academic advisors and commercial product development for life sciences research markets.
Company-building or leadership context
Deepcell continued commitment from Stanford-era founding through commercial platform development blending microfluidics, optics, and AI per about page narrative. The company pushes boundaries of cell science by fostering pioneering insights through multiple perspectives — hardware, software, and biology integrated.
Masaeli and Salek’s founder-CTO pairing mirrors common deep-tech life sciences structures where scientific co-founder leads technology while CEO drives commercialization partnerships.
Public milestones
Deepcell about page documents Stanford University founding context and current leadership with Masaeli as Founder and CEO. The company markets morphological cell analysis technology on deepcell.com reviewed 2026.
Masaeli is named Founder and CEO on deepcell.com/about reviewed July 10, 2026.
Why their work matters
Deepcell under Masaeli tests whether morphology-based cell classification can complement or replace marker-dependent sorting in research and diagnostic workflows — reducing labeling steps that alter cell behavior. AI interpretation of high-resolution cell images could enable discovery of cell states invisible to manual microscopy review at scale.
For healthcare AI readers, Deepcell is life-sciences research infrastructure — upstream of clinical AI but relevant to cell therapy and precision medicine pipelines.
Sources and references
Primary sourcing: Deepcell About page, reviewed July 10, 2026.
- Deepcell — About (deepcell.com)
Stanford founding context from official about page only.
Deepcell about page states the company pushes boundaries by blending AI-powered technology, microfluidics, and high-resolution optics across biological domains — a hardware-software-biology integration Masaeli’s CEO leadership coordinates with co-founder President and CTO Mahyar Salek. Stanford Scientific Advisory Board members including Euan Ashley and Catherine Blish per about page give Masaeli academic validation networks for morphology-based cell classification claims.
Deepcell’s mission to decode cell identity and function through morphology rather than destructive labeling addresses research bottlenecks in cell therapy and single-cell biology where traditional marker panels alter cell behavior — a product thesis Masaeli advances from Stanford lab origins documented on deepcell.com/about.
Deepcell about page invites candidates to join the team to morph their careers — reflecting Masaeli’s ongoing hiring scale as Founder and CEO building commercial morphology AI beyond academic research settings.